Blackstone Group Inc.

SEC CIK: 0001393818
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

NGM holding history

NGM Biopharmaceuticals Inc in every 13F filed by Blackstone Group Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NGM overview All 13F holders of NGM Full Q2 2026 holdings

Shares (Q3 2022): 0; Sold out in Q3 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2021

Holdings of NGM by Blackstone Group Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2022	0	$0	0.0%	−104,432−100.0%	Sold out	Holders
Q2 2022	104,432	$1.34M	<0.1%	+104,432	New	Holders
Q4 2021	0	$0	0.0%	−188,752−100.0%	Sold out	Holders
Q3 2021	188,752	$3.97M	<0.1%	+188,752	New	Holders